Heart Disease Clinical Trials in Seattle

Showing 41-60 of 117 trials

Repurposing Valsartan May Protect Against Pulmonary Hypertension

NCT06053580

This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension. The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.

Pulmonary Arterial HypertensionRight Heart FailureRight Ventricular Dysfunction+1 more

University of Washington60 participantsStarted Feb 2024

Seattle, Washington, United States

ACTIVE_NOT_RECRUITINGPHASE2/PHASE3< 1 mile

Communication During Hospitalization About Resuscitation Trial

NCT02984124

This multicenter RCT of 200 hospitalized patients and their family members evaluates an "informed assent" approach to discussing cardiopulmonary resuscitation, compared to usual care, in older seriously ill hospitalized patients with severe life-limiting illness or severe functional impairment.

Severe Life-limiting COPDSevere Life-limiting Heart FailureSevere Life-limiting Cirrhosis+3 more

University of Vermont182 participantsStarted Dec 2016

Chapel Hill, North Carolina, United States • Charleston, South Carolina, United States • Burlington, Vermont, United States +1 more locations

Repurposing Valsartan May Protect Against Pulmonary Hypertension

Communication During Hospitalization About Resuscitation Trial

Heart Disease Trials in Other Cities

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Multidisciplinary Approach for High-risk Patients Leading to Early Diagnosis of Canadians With Heart Failure

Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure

The Combined Portfolio Diet and Exercise Study

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Effect of Fetal Aortic Valvuloplasty on Outcomes

Other Conditions in Seattle